| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jul―03 |
Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in ex vivo and in vitro cultures of the human respiratory tract |
Denise I.T. Kuok, Angel P.Y. Ma, Rachel H.H. Ching, Ka Chun Ng, Jae W. Lee, Michael A. Matthay, Yi Guan, John M. Nicholls, Leo L.M. Poon, J.S. Malik Peiris, Kenrie P.Y. Hui, Michael C.W. Chan |
| 2 |
[GO] |
2026―Jun―25 |
Structural basis of porcine reproductive and respiratory syndrome virus 2 neutralization by a GP4-targeting monoclonal antibody |
Barbora Veselkova, Chandamita Saikia, Sebastian Affeldt, Sandra Barth, Manoj Kumar Rajak, Frithjof Besa, Daria Bezbakh, Guido Hansen, Till Rümenapf, Matthias Ballmaier, Oliver Dittrich-Breiholz, Holly Bamber, Kumar Nagarathinam, Alexander W. Tarr, Benjamin Lamp, Thomas Krey |
| 3 |
[GO] |
2026―Jun―16 |
A stable subgenomic reporter coronavirus enables transcriptional profiling of bystander cells |
Ciaran Gilbride, Joe Hemsley-Taylor, Catarina Nunes, Rebecca Penn, James Boot, Nima Pieris, Rupa Tripathy, Ziyi Yang, Matthew Hutchinson, Olivia K. Platt, Rachel Ulferts, Richard Mitter, Molly Strom, Nuno B. Santos, David L.V. Bauer, Harriet V. Mears |
| 4 |
[GO] |
2026―May―15 |
Serological response to feline coronavirus in the UK domestic cat population |
Hagar Sasvari, Lee Sherry, Nicola Logan, Dawn Dunbar, Grace B. Tyson, Christine Tait-Burkard, William Weir, Brian J Willett, Margaret J Hosie |
| 5 |
[GO] |
2026―May―14 |
Establishment of a human coronavirus HKU1 infection evaluation system using apical-out airway organoids |
Masatoshi Kakizaki, Satoko Sugimoto, Miyuki Kawase, Sakurako Norito, Hisao Okabe, Hayato Go, Koichi Hashimoto, Kazuya Shirato |
| 6 |
[GO] |
2026―May―05 |
Copper(II) benzyloxychalcone analogues as new potential metallodrugs against SARS-CoV-2 replication |
Igor Andrade Santos, Victoria Riquena Grosche, Laiane dos Santos Oliveira, Pedro Henrique de Souza Guarda, Gustavo Clauss Rodrigues, Rayany Cristina de Souza, Deborah Cristina Teixeira Alves, Andres Merits, Robinson Sabino-Silva, Dalan Bailey, Camilla Abbehausen, Mark Harris, Ana Carolina Gomes Jardim |
| 7 |
[GO] |
2026―Apr―22 |
Synergistic antiviral effect of host Adipose Triglyceride Lipase-directed DABPU-DE with coronavirus RNA-dependent RNA polymerase-targeting remdesivir on feline infectious peritonitis virus |
Shaimaa Aboelmagd, Seok In Han, Ragab Farouk, Dae-Eun Cheong, Hae-Rang Seo, Dong Ju Lee, Sunwoo Lee, Kyoung-Oh Cho |
| 8 |
[GO] |
2026―Mar―25 |
SARS-CoV-2 Nsp15 facilitates immune evasion and viral replication by limiting multiple host innate immune pathways, including cGAS-STING |
Hsin-Ping Chiu, Yao Yu Yeo, Tsoi Ying Lai, Chuan-Tien Hung, Shreyas Kowdle, Griffin D. Haas, Sizun Jiang, Weina Sun, Benhur Lee |
| 9 |
[GO] |
2026―Mar―05 |
Immunogenicity of SARS-CoV-2 vaccine prototype based on virus-like particles of hepatitis B core antigen from genotype G and interleukin 12 expressing Semliki Forest virus as a genetic adjuvant |
Andris Dislers, Olga Nilova, Juris Jansons, Dace Skrastina, Janis Bogans, Ivars Petrovskis, Karina Spunde, Rolans Stepanovs, Andris Kazaks, Anna Zajakina, Irina Sominskaya |
| 10 |
[GO] |
2026―Feb―13 |
RNA interference screen against SARS-CoV-2 identifies proviral vesicular transport factors involved in release |
Holly E. M. Kerr, Alison Daniels, Sarah L. Fletcher, Nicky Craig, Marie O'Shea, Samantha J. Griffiths, Daniel Sachs, Sophie Donovan, Rennos Fragkoudis, Juergen G. Haas, Christine Tait-Burkard |
| 11 |
[GO] |
2026―Jan―23 |
Australian strains of the avian coronavirus infectious bronchitis virus predominantly target the respiratory tract rather than the kidneys in specific-pathogen-free chickens |
Jose A. Quinteros, Panayiotis Loukopoulos, Amir H. Noormohammadi, Glenn F. Browning, Mauricio J. C. Coppo, Paola K. Vaz, Alistair R. Legione, Omid Fahri, Dulari S. Thilakarathne, Adepeju E. Onasanya, Gayathri Gopakumar, Marzieh Armat, Andrés Diaz-Méndez |
| 12 |
[GO] |
2025―Dec―19 |
Identification and characterization of candidate inhibitors of the SARS-CoV-2 nsp14 3′-5′ exoribonuclease |
Victoria Easton, Martin J. McPhillie, Igor Andrade Santos, Philippa Hall, C. Patrick McClure, Stuart Astbury, Emanuelle Paci, Alexander St John, Colin W.G. Fishwick, Mark Harris |
| 13 |
[GO] |
2025―Dec―01 |
Robust antibody and T cell responses tracked longitudinally in patients with long COVID |
Marina Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Benjamin A. Krishna, Nyarie Sithole |
| 14 |
[GO] |
2025―Nov―19 |
Strong immunogenicity and protection against SARS-CoV-2 in hamsters induced by heterologous boost vaccination with an MVA-based COVID-19 vaccine candidate |
Sonja Ohrnberger, Christian Meyer zu Natrup, Sabrina Clever, Lisa-Marie Schünemann, Federico Armando, Malgorzata Ciurkiewicz, Wolfgang Baumgärtner, Georgia Kalodimou, Gerd Sutter, Alina Tscherne, Asisa Volz |
| 15 |
[GO] |
2025―Sep―22 |
Susceptibility of different mouse strains to SARS-CoV-2 spike receptor-binding domain protein-induced lung inflammation: a comparative study |
Yujeong Ha, Young Hyun Lee, Hyo-Sung Jo, Tae Woo Kwon, Yujin Seo, Dong Woon Kim, Ik-Hyun Cho |
| 16 |
[GO] |
2025―Sep―16 |
PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production |
Nhi Phan, Yelizaveta Zaytseva, Chia-Ching Lin, Mitali Mishra, Weina Sun, Paulina Pawlica |
| 17 |
[GO] |
2025―Sep―03 |
SARS-CoV-2 infection of substantia nigra pars compacta induces expression of miR-330-5p at 10 days post-infection |
Bishwa R. Pokharel, Niska Majumdar, Frank Williams, Abigail Dickerson, Hannah Croy, Jeffrey B. Eells, Alessandro Didonna, Srinivas Sriramula, Paul P. Cook, Shaw M. Akula |
| 18 |
[GO] |
2025―Aug―06 |
Activity and cellular distribution of ORF3a mutants of SARS-CoV-2 variants of concern |
Ulrike Breitinger, Zeina Ihab Seifeldin Zakaria, Haya Alaa Mahgoub, Anna-Lena Wiessler, Esra Tuerker, Carmen Villmann, Hans-Georg Breitinger |
| 19 |
[GO] |
2025―Jul―31 |
Evaluation of pandemic potential of the genotype 4 (G4) swine influenza virus using ex vivo and in vitro cultures of the human respiratory tract |
Jenny C.M. Chan, Rachel H.H. Ching, Hermione H.M. Kock, Teng Long, John M. Nicholls, J.S. Malik Peiris, Kenrie P.Y. Hui, Michael C.W. Chan |
| 20 |
[GO] |
2025―Jul―11 |
Coronaviruses in wild rodent and eulipotyphlan small mammals: a review of diversity, ecological implications and surveillance considerations |
Simon P. Jeeves, Jonathon D. Kotwa, David L. Pearl, Bradley S. Pickering, Jeff Bowman, Samira Mubareka, Claire M. Jardine |
| 21 |
[GO] |
2025―Jul―07 |
Arsenic trioxide could promote SARS-CoV-2 NSP12 protein degradation |
Tao Yang, Chen Ying Zhu, Pei Han Yu, Chang Yang, Hua Naranmandura |
| 22 |
[GO] |
2025―Jun―04 |
H5N1 2.3.4.4b: a review of mammalian adaptations and risk of pandemic emergence |
Fernando Capelastegui, Daniel H. Goldhill |
| 23 |
[GO] |
2025―Apr―04 |
Distribution of aminopeptidase N coronavirus receptors in the respiratory and digestive tracts of domestic and wild artiodactyls and carnivores |
Fabian Z.X. Lean, Giulia Gallo, Joseph Newman, Stuart Ackroyd, Simon Spiro, Ruth Cox, Ingebjørg Helena Nymo, Caroline Bröjer, Aleksija Neimanis, Alejandro Suárez-Bonnet, Simon L. Priestnall, Holly Everest, Sarah Keep, Dalan Bailey, Richard J. Delahay, Amanda H. Seekings, Lorraine M. McElhinney, Sharon M. Brookes, Alejandro Núñez |
| 24 |
[GO] |
2025―Feb―13 |
Comparative syncytia formation dynamics of coronavirus MHV-A59 and pneumovirus hRSV A2 and incorporation into improved kinetic virus replication models |
Emily H. Landwehr, Lyla R. Vivian, George G. Papadeas, Ethan J. White, Jayden M. Doster, Nicholas R. Brenner, Kara M. Selesky, Cora A. Zilinski, Angelena M. Donovan, Stefania M. Farha, Lindsay Lewellyn, Dia C. Beachboard, Scott Kaschner, Christopher C. Stobart |
| 25 |
[GO] |
2025―Feb―12 |
Examining the feasibility of replacing ORF3a with fluorescent genes to construct SARS-CoV-2 reporter viruses |
Isobel Webb, Maximillian Erdmann, Rachel Milligan, Megan Savage, David A. Matthews, Andrew D. Davidson |
| 26 |
[GO] |
2025―Jan―30 |
Linking the function of cis-acting RNA elements to coronavirus replication using interactomes |
Yueh-Chun Yao, Chun-Chun Yang, Meilin Wang, Feng-Cheng Hsieh, Ching-Hung Lin, Hsuan-Wei Hsu, Chien-Chen Lai, Wei-Chen Wang, Cheng-Yu Kuo, Cheng-Yao Yang, Hung-Yi Wu |
| 27 |
[GO] |
2025―Jan―13 |
HIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity |
Kate L. Morling, Mohamed ElGhazaly, Richard S. B. Milne, Greg J. Towers |
| 28 |
[GO] |
2025―Jan―09 |
A yeast-assembled, plasmid-launched reverse genetics system for the murine coronavirus MHV-A59 |
Cade E. Sterling, Natalie R. Wilson, Debreiona Y. Harris, Everett Clinton Smith |
| 29 |
[GO] |
2024―Dec―20 |
Comparison of different T cell assays for the retrospective determination of SARS-CoV-2 infection |
Benjamin Krishna, Marina Metaxaki, Marianne Perera, Mark Wills, Nyarie Sithole |
| 30 |
[GO] |
2024―Oct―30 |
BALB/c mice challenged with SARS-CoV-2 B.1.351 β variant cause pathophysiological and neurological changes within the lungs and brains |
Panatda Saenkham-Huntsinger, Aleksandra K. Drelich, Pinghan Huang, Bi-Hung Peng, Chien-Te K. Tseng |
| 31 |
[GO] |
2024―Sep―18 |
SARS-CoV-2 infection and transmission via the skin to oro-nasal route with the production of bioaerosols in the ferret model |
Rebecca Shipley, Amanda H. Seekings, Alexander M.P. Byrne, Shweta Shukla, Joe James, Hooman Goharriz, Fabian Z.X. Lean, Alejandro Núñez, Anthony R. Fooks, Lorraine M. McElhinney, Sharon M. Brookes |
| 32 |
[GO] |
2024―Aug―19 |
Diversifying selection identified in immune epitopes of bovine coronavirus isolates from Irish cattle |
Tristan Russell, Jose Maria Lozano, Cailyn Challinor, Gerald Barry |
| 33 |
[GO] |
2024―Jul―12 |
SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system in vitro |
Ruth Haverty, Janet McCormack, Christopher Evans, Kevin Purves, Sophie O'Reilly, Virginie Gautier, Keith Rochfort, Aurelie Fabre, Nicola F. Fletcher |
| 34 |
[GO] |
2024―May―22 |
Role of N-linked glycosylation in porcine reproductive and respiratory syndrome virus (PRRSV) infection |
Raymond R.R. Rowland, Alberto Brandariz-Nuñez |
| 35 |
[GO] |
2024―May―08 |
Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic |
Yalcin Kara, Mahmut Can Kizil, Merve İşeri Nepesov, Ebru Kaçmaz, Eylem Kiral, Gurkan Bozan, Gül Durmaz, Tercan Us, Ömer Kiliç, Ener Çağrı Dinleyici |
| 36 |
[GO] |
2024―Jan―25 |
Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein |
Christopher L. D. McMillan, Danushka K. Wijesundara, Jovin J. Y. Choo, Alberto A. Amarilla, Naphak Modhiran, Germain J. P. Fernando, Alexander A. Khromykh, Daniel Watterson, Paul R. Young, David A. Muller |
| 37 |
[GO] |
2023―Dec―07 |
Lack of detection of SARS-CoV-2 in British wildlife 2020-21 and first description of a stoat (Mustela erminea) Minacovirus |
Ternenge Apaa, Amy J. Withers, Laura Mackenzie, Ceri Staley, Nicola Dessi, Adam Blanchard, Malcolm Bennett, Samantha Bremner-Harrison, Elizabeth A. Chadwick, Frank Hailer, Stephen W. R. Harrison, Xavier Lambin, Matthew Loose, Fiona Mathews, Rachael Tarlinton |
| 38 |
[GO] |
2023―Nov―24 |
Evolution of the coronavirus spike protein in the full-length genome and defective viral genome under diverse selection pressures |
Ching-Hung Lin, Hon-Man-Herman Tam, Cheng-Yao Yang, Feng-Cheng Hsieh, Jiun-Long Wang, Chun-Chun Yang, Hsuan-Wei Hsu, Hao-Ping Liu, Hung-Yi Wu |
| 39 |
[GO] |
2023―Nov―10 |
SARS-CoV-2 and the DNA damage response |
Roger J. Grand |
| 40 |
[GO] |
2023―Oct―10 |
Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications |
Chidiebere F. Uchechukwu, Uchechukwu Love Anyaduba, Chukwuemeka Chinedum Udekwu, Oluwatosin Qawiyy Orababa, Ayomikun Emmanuel Kade |
| 41 |
[GO] |
2023―Oct―06 |
MERS-CoV and SARS-CoV-2 membrane proteins are modified with polylactosamine chains |
Dylan Juckel, Lowiese Desmarets, Adeline Danneels, Yves Rouillé, Jean Dubuisson, Sandrine Belouzard |
| 42 |
[GO] |
2023―Aug―31 |
A novel chimeric vaccine candidate for porcine reproductive and respiratory syndrome virus (PRRSV) I and II elicits neutralizing antibodies against both types |
Sang-Ho Cha, Bang-Hun Hyun, Hyang-Sim Lee, Seok-Jin Kang, Su-Hwa You, Jiwoon Jeong, Chang-Joo Park, Myung-Shin Lee, Changhoon Park |
| 43 |
[GO] |
2023―Aug―31 |
Continued adaptation of A/H2N2 viruses during pandemic circulation in humans |
Jasmin S. Kutter, Martin Linster, Dennis de Meulder, Theo M. Bestebroer, Pascal Lexmond, Miruna E. Rosu, Mathilde Richard, Robert P. de Vries, Ron A. M. Fouchier, Sander Herfst |
| 44 |
[GO] |
2023―Jul―26 |
Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 |
Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, Juthathip Mongkolsapaya, Gavin Screaton, Matthew Wand, Michael J. Elmore, Miles W. Carroll, Ian Matthews, Howard Thomas |
| 45 |
[GO] |
2023―Jul―11 |
Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 |
Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, Juthathip Mongkolsapaya, Gavin Screaton, Matthew Wand, Michael J. Elmore, Miles W. Carroll, Ian Matthews, Howard Thomas |
| 46 |
[GO] |
2023―Jun―21 |
ARF6 is a host factor for SARS-CoV-2 infection in vitro |
C. Mirabelli, J. Bragazzi Cunha, J. W. Wotring, E. J. Sherman, J. El Saghir, J. Harder, M. Kretzler, J. Z. Sexton, B. T. Emmer, C. E. Wobus |
| 47 |
[GO] |
2023―May―11 |
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1 |
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, Arturo Casadevall, Daniele Focosi |
| 48 |
[GO] |
2023―Feb―17 |
The health of influenza surveillance and pandemic preparedness in the wake of the COVID-19 pandemic |
Rodney Stuart Daniels, John William McCauley |
| 49 |
[GO] |
2023―Feb―14 |
A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model |
Kevin Purves, Ruth Haverty, Tiina O'Neill, David Folan, Sophie O'Reilly, Alan W. Baird, Dimitri Scholz, Patrick W. Mallon, Virginie Gautier, Michael Folan, Nicola F. Fletcher |
| 50 |
[GO] |
2022―Nov―22 |
Infectious droplet exposure is an inefficient route for SARS-CoV-2 infection in the ferret model |
Joe James, Alexander M. P. Byrne, Hooman Goharriz, Megan Golding, Joan M. A. Cuesta, Benjamin C. Mollett, Rebecca Shipley, Lorraine M. McElhinney, Anthony R. Fooks, Sharon M. Brookes |
| 51 |
[GO] |
2022―Oct―25 |
Retraction notice: The middle half genome of interferon-inducing porcine reproductive and respiratory syndrome virus strain A2MC2 is essential for interferon induction |
|
| 52 |
[GO] |
2022―May―04 |
Mutations within scavenger receptor cysteine-rich (SRCR) protein domain 5 of porcine CD163 involved in infection with porcine reproductive and respiratory syndrome virus (PRRS) |
Ana M. M. Stoian, Raymond R. R. Rowland, Alberto Brandariz-Nuñez |
| 53 |
[GO] |
2022―Apr―04 |
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges |
Nazia Thakur, Giulia Gallo, Joseph Newman, Thomas P. Peacock, Luca Biasetti, Catherine N. Hall, Edward Wright, Wendy Barclay, Dalan Bailey |
| 54 |
[GO] |
2022―Jan―11 |
Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2 |
Katarzyna Piadel, Amin Haybatollahi, Angus George Dalgleish, Peter Lawrence Smith |
| 55 |
[GO] |
2021―Nov―24 |
Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples |
Aleksander Szymczak, Natalia Jędruchniewicz, Alessandro Torelli, Agata Kaczmarzyk-Radka, Rosa Coluccio, Marlena Kłak, Andrzej Konieczny, Stanisław Ferenc, Wojciech Witkiewicz, Emanuele Montomoli, Paulina Miernikiewicz, Remigiusz Bąchor, Krystyna Dąbrowska |
| 56 |
[GO] |
2021―Nov―17 |
Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale |
Kelvinson Viana, Luis Zarpelon, Andre Leandro, Maria Terencio, Renata Lopes, Caroline Martins, Isaak Silva, Alessandra Sibim, Fábio Marques, Rafael da Silva, Açucena Rivas, Adrieli Souza, Angelo dos-Santos, Sara Torres, Maria Garcia, Rodolfo Giunchetti, Wagner Chiba-de-Castro |
| 57 |
[GO] |
2021―Oct―27 |
MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation |
Yuting Jiang, Yuehong Chen, Hong Sun, Xiaolu Zhang, Lei He, Jiangfan Li, Guangyu Zhao, Shihui Sun |
| 58 |
[GO] |
2021―Oct―08 |
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2 |
Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, Michael Pritsch, Inge Kroidl, Elmar Saathoff, Jessica Michelle Guggenbuehl Noller, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Philine Falk, Alisa Markgraf, Flora Deák, Friedrich Riess, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Marc Becker, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Roman Wölfel, Jan Hasenauer, Michael Hoelscher, Andreas Wieser |
| 59 |
[GO] |
2021―Sep―15 |
Prevalence and molecular characteristics of feline coronavirus in southwest China from 2017 to 2020 |
Qun Zhou, Yan Li, Jian Huang, Nengsheng Fu, Xin Song, Xue Sha, Bin Zhang |
| 60 |
[GO] |
2021―Aug―23 |
Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present |
Phoebe Stevenson-Leggett, Stuart Armstrong, Sarah Keep, Paul Britton, Erica Bickerton |
| 61 |
[GO] |
2021―Jul―28 |
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir |
Marie O. Pohl, Idoia Busnadiego, Francesco Marrafino, Lars Wiedmer, Annika Hunziker, Sonja Fernbach, Irina Glas, Elena V. Moroz-Omori, Benjamin G. Hale, Amedeo Caflisch, Silke Stertz |
| 62 |
[GO] |
2021―Jun―16 |
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom |
Joseph G. Chappell, Theocharis Tsoleridis, Gemma Clark, Louise Berry, Nadine Holmes, Christopher Moore, Matthew Carlile, Fei Sang, Bisrat J. Debebe, Victoria Wright, William L. Irving, Brian J. Thomson, Timothy C. J. Boswell, Iona Willingham, Amelia Joseph, Wendy Smith, Manjinder Khakh, Vicki M. Fleming, Michelle M. Lister, Hannah C. Howson-Wells, Edward C. Holmes, Matthew W. Loose, Jonathan K. Ball, C. Patrick McClure |
| 63 |
[GO] |
2021―May―06 |
Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells |
Thrimendra Kaushika Dissanayake, Bingpeng Yan, Anthony Chin-Ki Ng, Hanjun Zhao, Gabriella Chan, Cyril Chik-Yan Yip, Kong-Hung Sze, Kelvin Kai-Wang To |
| 64 |
[GO] |
2021―May―06 |
SARS-CoV-2 replicon for high-throughput antiviral screening |
Qiu-Yan Zhang, Cheng-Lin Deng, Jing Liu, Jia-Qi Li, Hong-Qing Zhang, Na Li, Ya-Nan Zhang, Xiao-Dan Li, Bo Zhang, Yi Xu, Han-Qing Ye |
| 65 |
[GO] |
2021―Apr―29 |
Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes |
Katherine Davies, Hubert Buczkowski, Stephen R. Welch, Nicole Green, Damian Mawer, Neil Woodford, Allen D. G. Roberts, Peter J. Nixon, David W. Seymour, Marian J. Killip |
| 66 |
[GO] |
2021―Apr―23 |
Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2 |
Sophie J. Smither, Lin S. Eastaugh, James S. Findlay, Thomas R. Laws, Stephen N. Marriott, Stuart Notman, Lyn M. O’Brien, Amanda L. Phelps, Mark Richards, David Ulaeto, Pat Watts, Mark S. Lever, Norman Govan |
| 67 |
[GO] |
2021―Apr―15 |
SARS-CoV-2 one year on: evidence for ongoing viral adaptation |
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, Wendy S. Barclay |
| 68 |
[GO] |
2021―Apr―08 |
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection |
Lisa Henss, Arne Auste, Christoph Schürmann, Christin Schmidt, Christine von Rhein, Michael D. Mühlebach, Barbara S. Schnierle |
| 69 |
[GO] |
2021―Feb―22 |
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2 |
Elodie Monchatre-Leroy, Sandrine Lesellier, Marine Wasniewski, Evelyne Picard-Meyer, Céline Richomme, Franck Boué, Sandra Lacôte, Séverine Murri, Coralie Pulido, Johann Vulin, Francisco J. Salguero, Meriadeg Ar Gouilh, Alexandre Servat, Philippe Marianneau |
| 70 |
[GO] |
2021―Feb―15 |
A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India |
Asmita Gupta, Radhakrishnan Sabarinathan, Pratyusha Bala, Vinay Donipadi, Divya Vashisht, Madhumohan Rao Katika, Manohar Kandakatla, Debashis Mitra, Ashwin Dalal, Murali Dharan Bashyam |
| 71 |
[GO] |
2021―Jan―28 |
Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19 |
Molly K. Roe, Nathan A. Junod, Audrey R. Young, Dia C. Beachboard, Christopher C. Stobart |
| 72 |
[GO] |
2021―Jan―11 |
A genetic element in the SARS-CoV-2 genome is shared with multiple insect species |
Torstein Tengs, Charles F. Delwiche, Christine Monceyron Jonassen |
| 73 |
[GO] |
2021―Jan―08 |
Assessment of inactivation procedures for SARS-CoV-2 |
Heidi Auerswald, Sokhoun Yann, Sokha Dul, Saraden In, Philippe Dussart, Nicholas J. Martin, Erik A. Karlsson, Jose A. Garcia-Rivera |
| 74 |
[GO] |
2020―Dec―17 |
Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit? |
Peter Simmonds, Sarah Williams, Heli Harvala |
| 75 |
[GO] |
2020―Nov―05 |
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression |
Zhou Shen, Guangxu Zhang, Yilin Yang, Mengxia Li, Siqi Yang, Guiqing Peng |
| 76 |
[GO] |
2020―Sep―30 |
Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020 |
Mark Harris |
| 77 |
[GO] |
2020―Sep―09 |
Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus |
Arinjay Banerjee, Andrew C. Doxey, Benjamin J.-M. Tremblay, Michael J. Mansfield, Sonu Subudhi, Jeremy A. Hirota, Matthew S. Miller, Andrew G. McArthur, Samira Mubareka, Karen Mossman |
| 78 |
[GO] |
2020―Sep―09 |
Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses |
David A. Wilkinson, Léa Joffrin, Camille Lebarbenchon, Patrick Mavingui |
| 79 |
[GO] |
2020―Sep―07 |
Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus |
Debin Tian, Sakthivel Subramaniam, C. Lynn Heffron, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, Qian M. Cao, Anna Hassebroek, Tanya LeRoith, Dennis L. Foss, Jay G. Calvert, Xiang-Jin Meng |
| 80 |
[GO] |
2020―Aug―21 |
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients |
William B. Klimstra, Natasha L. Tilston-Lunel, Sham Nambulli, James Boslett, Cynthia M. McMillen, Theron Gilliland, Matthew D. Dunn, Chengun Sun, Sarah E. Wheeler, Alan Wells, Amy L. Hartman, Anita K. McElroy, Douglas S. Reed, Linda J. Rennick, W. Paul Duprex |
| 81 |
[GO] |
2020―Jul―28 |
Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus |
Sarah Keep, Michael S. Oade, Filip Lidzbarski-Silvestre, Kirsten Bentley, Phoebe Stevenson-Leggett, Graham L. Freimanis, Chandana Tennakoon, Nicholas Sanderson, John A. Hammond, Richard C. Jones, Paul Britton, Erica Bickerton |
| 82 |
[GO] |
2020―Jul―15 |
A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a |
Andrew E. Firth |
| 83 |
[GO] |
2020―Jun―24 |
Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems |
Severino Jefferson Ribeiro da Silva, Renata Pessôa Germano Mendes, Caroline Targino Alves da Silva, Alessio Lorusso, Alain Kohl, Lindomar Pena |
| 84 |
[GO] |
2020―Jun―15 |
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection |
Jingfang Wang, Xintian Xu, Xinbo Zhou, Ping Chen, Huiying Liang, Xuan Li, Wu Zhong, Pei Hao |
| 85 |
[GO] |
2020―May―20 |
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection |
Paul Kellam, Wendy Barclay |
|
